Zoekresultaten

Effects of urban trees on local outdoor microclimate: synthesizing field measurements by numerical modelling

Health in SIA [social impact assessment]

SIA developed alongside EIA in the early 1970s as a mechanism to consider the social impacts of planned interventions. The early understanding tended to limit the practical application of SIA to the project level, usually within the context of regulatory frameworks, and primarily considered only the direct negative impacts. However, like other types of impact assessment, SIA has evolved over time and has diverged considerably from EIA.

Socio-psychological effects of wind turbine noise

This paper presents a report of some of the activities of the International Energy Agency's (IEA) Wind TCP Task 39. By identifying best practices in an international collaboration, Task 39 hopes to provide the scientific evidence to inform improved regulations and standards, increasing the effectiveness of quiet wind turbine technology. Task 39 is divided into five separate work packages, which address the broad wind turbine noise topic in successive steps; from wind turbine noise generation (WP2), to airborne noise propagation over large distances (WP3). The assessment of wind turbine noise and its impact on humans is addressed in WP4, while WP5 is dealing with other aspects of perception and acceptance, which may be related to noise. All WPs contribute to a dedicated Work Package on dissemination (WP1). This paper provides an update of activities primarily associated with the socio-psychological aspects of wind turbine noise (WP4 and WP5). Through the consideration of a wide variety of factors, including measurement technologies, auralisation and psychology, the effects on noise perception, annoyance and its impact on wellbeing and health is being further investigated. This paper presents a discussion of the activities of each member country and highlights some of the key research questions that need to be further considered.

In-depth assessment of the situation of the textile and clothing sector in the EU and prospects

The in-depth assessment of the situation of the European textile and clothing sector is composed by six independent reports with a close focus on key aspects useful to understand the dynamics and the development of the textile and clothing industry, drivers of change – most notably the impact of the financial crisis – and identification of policy responses and best practices. This has been done in six specific tasks leading to the six reports: Task 1 Survey on the situation of the EU textile and clothing sector Task 2 Report on research and development Task 3 Report on SME situation Task 4 Report on restructuring Task 5 Report on training and Education Task 6 Report on innovation practices The aim of Task 2 was to analyse in detail how specialised research an innovation centres liaise with textile/clothing enterprises and analyse the process of transforming textile/clothing research innovations into new products/processes available in the market.

The Financial Credit Risk Assessment Model

Within recent years, Financial Credit Risk Assessment (FCRA) has become an increasingly important issue within the financial industry. Therefore, the search for features that can predict the credit risk of an organization has increased. Using multiple statistical techniques, a variance of features has been proposed. Applying a structured literature review, 258 papers have been selected. From the selected papers, 835 features have been identified. The features have been analyzed with respect to the type of feature, the information sources needed and the type of organization that applies the features. Based on the results of the analysis, the features have been plotted in the FCRA Model. The results show that most features focus on hard information from a transactional source, based on official information with a high latency. In this paper, we readdress and -present our earlier work [1]. We extended the previous research with more detailed descriptions of the related literature, findings, and results, which provides a grounded basis from which further research on FCRA can be conducted.

Association between early cumulative fluid balance and successful liberation from invasive ventilation in COVID-19 ARDS patients - insights from the PRoVENT-COVID study

BACKGROUND: Increasing evidence indicates the potential benefits of restricted fluid management in critically ill patients. Evidence lacks on the optimal fluid management strategy for invasively ventilated COVID-19 patients. We hypothesized that the cumulative fluid balance would affect the successful liberation of invasive ventilation in COVID-19 patients with acute respiratory distress syndrome (ARDS).METHODS: We analyzed data from the multicenter observational 'PRactice of VENTilation in COVID-19 patients' study. Patients with confirmed COVID-19 and ARDS who required invasive ventilation during the first 3 months of the international outbreak (March 1, 2020, to June 2020) across 22 hospitals in the Netherlands were included. The primary outcome was successful liberation of invasive ventilation, modeled as a function of day 3 cumulative fluid balance using Cox proportional hazards models, using the crude and the adjusted association. Sensitivity analyses without missing data and modeling ARDS severity were performed.RESULTS: Among 650 patients, three groups were identified. Patients in the higher, intermediate, and lower groups had a median cumulative fluid balance of 1.98 L (1.27-7.72 L), 0.78 L (0.26-1.27 L), and - 0.35 L (- 6.52-0.26 L), respectively. Higher day 3 cumulative fluid balance was significantly associated with a lower probability of successful ventilation liberation (adjusted hazard ratio 0.86, 95% CI 0.77-0.95, P = 0.0047). Sensitivity analyses showed similar results.CONCLUSIONS: In a cohort of invasively ventilated patients with COVID-19 and ARDS, a higher cumulative fluid balance was associated with a longer ventilation duration, indicating that restricted fluid management in these patients may be beneficial. Trial registration Clinicaltrials.gov ( NCT04346342 ); Date of registration: April 15, 2020.